ITK and allergic asthma: ITK is thought to drive Th2-mediated disease such as allergic asthma, and ITK-/- mice exhibit significantly improved disease course and reduced bronchoconstriction after antigen re-challenge in ovalbumin sensitized mice [2, 4].